2nd Quarter - Report — HUMANA, INC. for HUMANA INC (2018)

Firm

HUMANA, INC.

Client

HUMANA INC

Income

—

Expenses

$310,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

4 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Tricare Issues H.R. 2810/S. 1519, FY 2018 National Defense Authorization Act Implementation H.R. 5515 and S. 2987, FY 2019 National Defense Authorization Act

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); SENATE; HOUSE OF REPRESENTATIVES; White House Office; Treasury, Dept of; Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS)

Bills named: S. 2987 (115th), H.R. 2810 (115th), S. 1519 (115th), H.R. 5515 (115th)

Taxation/Internal Revenue Code TAX

H.R. 246, Jobs and Premium Protection Act H.R. 4620, Protecting Families and Small Business Act S. 1859, Healthcare Tax Relief Act S. 1978, Small Business and Family Health Tax Relief Act H.R. 5963, Health Insurance Premium Reduction Act S. 3063, Health Insurance Tax Relief Act of 2018 HSA Tax Treatment Tax Reform Implementation (P.L. 115-97)

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Treasury, Dept of; SENATE; White House Office; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS)

Bills named: S. 1859 (115th), H.R. 4620 (115th), S. 1978 (115th), H.R. 246 (115th), H.R. 5963 (115th), S. 3063 (115th)

Health Issues HCR

Bipartisan Healthcare Stabilization Act (Alexander-Murray) Affordable Care Act Implementation H.R. 2026 Pharmaceutical Information Exchange Act H.R. 878, H.R. 2368, S. 204 Right-to-Try Legislation Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB)

Bills named: H.R. 878 (115th), H.R. 2368 (115th), H.R. 2026 (115th), S. 204 (115th)

Medicare/Medicaid MMM

Medicare Advantage Policy and Reimbursement Part D Policy and Reimbursement Medicaid and Dual Eligible Issues Pharmacy Reimbursement Issues Medicare Access and CHIP Reauthorization Act Implementation Opioid Issues H.R. 6, Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act S. 637, Creating Transparency to Have Drug Rebates Unlocked Act H.R. 3528, Every Prescription Conveyed Securely Act Request for Information 0991-ZA49, HHS Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

Lobbyist	Covered position, as disclosed
RACHEL MAGNUSON	—
DEBRA OBERMAN	—
DOUGLAS STOSS	—

Contacted: Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); SENATE; Treasury, Dept of; Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; White House Office

Bills named: S. 637 (115th), H.R. 3528 (115th), H.R. 6 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.